Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) remains a morbid disease with poor prognosis and treatment that typically leaves patients with permanent damage to critical functions such as eating and talking. Currently only three targeted therapies are FDA approved for use in HNSCC, two of which are...

Descripción completa

Detalles Bibliográficos
Autores principales: Choonoo, Gabrielle, Blucher, Aurora S., Higgins, Samuel, Boardman, Mitzi, Jeng, Sophia, Zheng, Christina, Jacobs, James, Anderson, Ashley, Chamberlin, Steven, Evans, Nathaniel, Vigoda, Myles, Cordier, Benjamin, Tyner, Jeffrey W., Kulesz-Martin, Molly, McWeeney, Shannon K., Laderas, Ted
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785123/
https://www.ncbi.nlm.nih.gov/pubmed/31596908
http://dx.doi.org/10.1371/journal.pone.0223639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785123/
https://www.ncbi.nlm.nih.gov/pubmed/31596908
http://dx.doi.org/10.1371/journal.pone.0223639

Ejemplares similares